Estimated Association of a COVID-19 Diagnosis With Neurologic or Immune-Mediated Outcomes: Analysis Starting Follow-Up on the Day After Time 0.
<p>CI = confidence interval; HR = hazard ratio; NA = not applicable; NE = not estimable; RI = relative incidence; SCRI = self-controlled risk interval. Note: Encephalitis/encephalomyelitis was not evaluated with the SCRI design because of its known high case fatality rate.</p>...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Andere auteurs: | , , , , , , , , , , , , , , , , , , , , , |
| Gepubliceerd in: |
2025
|
| Onderwerpen: | |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
| Samenvatting: | <p>CI = confidence interval; HR = hazard ratio; NA = not applicable; NE = not estimable; RI = relative incidence; SCRI = self-controlled risk interval. Note: Encephalitis/encephalomyelitis was not evaluated with the SCRI design because of its known high case fatality rate.</p> |
|---|